Table 4 Variation of amino acid sequence of bacteriocin.

From: Comprehensive analysis of bacteriocins produced by clinical enterococcal isolates and their antibacterial activity against Enterococci including VRE

 

Number of strains

characteristics

Cytolysin variants

 CytL-La

46 (93.9%)

 

 CytL-Lb

1 (2.0%)

1 amino acid substitution

 CytL-S-a

46 (93.9%)

 

 CytL-S-b

1 (2.0%)

1 amino acid substitution

 CytL-LS-fusion

2 (4.1%)

2 orf fused

Enterolysin A variants

 Enterolysin A-a

18 (81.8%)

 

 Enterolysin A-b

1 (4.5%)

1 amino acid substitution

 Enterolysin A-c

1 (4.5%)

25 amino acids substitution

 Enterolysin A-d

1 (4.5%)

25 amino acids substitution

 Enterolysin A-e

1 (4.5%)

23 amino acids substitution

BacL1 variants

 BacL1 -a

33 (91.7%)

 

 BacL1 -b

1 (2.9%)

orf disrupted

 BacL1 -c

1 (2.9%)

1 amino acid substitution

 BacL1 -d

1 (2.9%)

2 amino acids substitution

Back to article page